✦ LIBER ✦
A randomized double-blind, placebo-controlled study to assess the effects of omalizumab (humanized monoclonal anti-IgE antibody) on the early- and late-phase skin reactions and cellular infiltrate after multiple intradermal allergen challenges*1
✍ Scribed by ONG, Y
- Book ID
- 119273541
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 25 KB
- Volume
- 113
- Category
- Article
- ISSN
- 1097-6825
No coin nor oath required. For personal study only.